ABS44
Anti-MAPK 1/2 Antibody
from rabbit
Szinonimák:
ERK-1, ERT2, Extracellular signal-regulated kinase 1, Insulin-stimulated MAP2 kinase, MAP kinase 3, MAP kinase isoform p44, MAPK 3, Microtubule-associated protein 2 kinase, Mitogen-activated protein kinase 3, MNK1, p44-ERK1, p44-MAPK, ERK-2, ERT1, Extrac
Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez
Összes fotó(3)
About This Item
UNSPSC kód:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Javasolt termékek
biológiai forrás
rabbit
Minőségi szint
antitest forma
purified antibody
antitest terméktípus
primary antibodies
klón
polyclonal
faj reaktivitás
human, mouse, rat
faj reaktivitás (homológia által előrejelzett)
canine (based on 94% sequence homology), bovine (based on 94% sequence homology)
technika/technikák
immunocytochemistry: suitable
immunoprecipitation (IP): suitable
western blot: suitable
NCBI elérési szám
UniProt elérési szám
kiszállítva
wet ice
célzott transzláció utáni módosítás
unmodified
Géninformáció
human ... MAPK1(5594)
Általános leírás
Mitogen-activated protein kinase 3 (EC 2.7.11.24; UniProt P21708; also known as ERK-1, ERT2, Extracellular signal-regulated kinase 1, Insulin-stimulated MAP2 kinase, MAP kinase 3, MAP kinase isoform p44, MAPK 3, Microtubule-associated protein 2 kinase, MNK1, p44-ERK1, p44-MAPK) is encoded by the Mapk3 (also known as Erk1, Prkm3) gene (Gene ID 50689) in rat species. ERK1 (a.k.a. MAPK 3) and ERK2 (a.k.a. MAPK 1 or MAPK 2) are related serine/threonine kinases of the Ras-Raf-MEK-ERK signaling pathway. ERK1/2 are activated by MEK1/2-catalyzed phosphorylation at their conserved Thr-Glu-Tyr (TEY) dual phosphorylation motif, first at the Tyr residue (human/rat ERK1 Tyr204/Tyr203, human/rat ERK2 Tyr187/Tyr183) and then at the Thr residue (human/rat ERK1 Thr202/Thr201, human/rat ERK2 Thr185/Thr181). ERK1/2 are proline-directed kinases that preferentially catalyze the phosphorylation of Pro-Xxx-Ser/Thr-Pro sequence motif in hundreds of cytoplasmic and nuclear substrates, including transcription factors such as Ets, Elk, and c-Fos. Besides this primary structure requirement, many ERK1/2 substrates possess a D-docking site and/or an F-docking site. A variety of scaffold proteins, including KSR1/2, IQGAP1, MP1, and β-Arrestin1/2, also participate in the regulation of ERK1/2 MAP kinase cascade. Ras-Raf-MEK-ERK signaling activity is upregulated in about one-third of all human cancers, and targeted inhibition against components of this signaling pathway represents a popular anticancer strategy.
Egyediség
This antibody recognizes MAPK 3/MAPK 1 (ERK1/ERK2) C-terminal sequence.
Immunogen
Epitope: C-terminal
KLH-conjugated linear peptide corresponding to the C-terminal sequence of rat MAPK 3 (ERK-1).
Alkalmazás
Detect MAPK 3/MAPK 1 (ERK1/ERK2) using this Anti-MAPK 1/2 Antibody validated for use in Immunocytochemistry, Immunoprecipitation, and Western Blotting.
Research Category
Signaling
Signaling
Research Sub Category
MAP Kinases
MAP Kinases
Western Blotting Analysis: 0.5 µg/mL from a representative lot detected MAPK 3/MAPK 1 (ERK1/ERK2) in BALB/3T3, A431, and L6 cell lysates.
Western Blotting (SNAP ID) Analysis: 1-2 µg/mL from a representative lot detected MAPK 3/MAPK 1 (ERK1/ERK2) in BALB/3T3, A431, and L6 cell lysates.
Immunocytochemistry Analysis: A 1:500 dilution from a representative lot detected MAPK 3/MAPK 1 (ERK1/ERK2) in NIH/3T3, A431, HeLa, and C2C12 cells.
Western Blotting (SNAP ID) Analysis: 1-2 µg/mL from a representative lot detected MAPK 3/MAPK 1 (ERK1/ERK2) in BALB/3T3, A431, and L6 cell lysates.
Immunocytochemistry Analysis: A 1:500 dilution from a representative lot detected MAPK 3/MAPK 1 (ERK1/ERK2) in NIH/3T3, A431, HeLa, and C2C12 cells.
Minőség
Evaluated by Western Blotting in A431 cell lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected MAPK 3/MAPK 1 (ERK1/ERK2) in 10 µg of A431 cell lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected MAPK 3/MAPK 1 (ERK1/ERK2) in 10 µg of A431 cell lysate.
Cél megnevezése
~44/42 kDa observed. 41.26/36.30 kDa (human MAPK1 isoform 1/2), 41.14 kDa (rat MAPK1), 41.14 kDa (mouse MAPK1), 43.00/38.14 kDa (human MAPK3 isoform 1/2), 42.95/45.64 kDa (rat MAPK3 isoform 1/2), 42.93 kDa (mouse MAPK3) calculated (Met1 removed). Target sequence is not present in human MAPK3 spliced isoform 3 (ERK1b).
Kapcsolódás
Replaces: 06-182
Fizikai forma
Format: Purified
Protein A purified.
Purified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Tárolás és stabilitás
Stable for 1 year at 2-8°C from date of receipt.
Analízis megjegyzés
Control
A431 cell lysate
A431 cell lysate
Egyéb megjegyzések
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Jogi nyilatkozat
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Nem találja a megfelelő terméket?
Próbálja ki a Termékválasztó eszköz. eszközt
javasolt
Tárolási osztály kódja
12 - Non Combustible Liquids
WGK
WGK 1
Lobbanási pont (F)
Not applicable
Lobbanási pont (C)
Not applicable
Analitikai tanúsítványok (COA)
Analitikai tanúsítványok (COA) keresése a termék sarzs-/tételszámának megadásával. A sarzs- és tételszámok a termék címkéjén találhatók, a „Lot” vagy „Batch” szavak után.
Már rendelkezik ezzel a termékkel?
Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.
Shouma Ishikawa et al.
Biological & pharmaceutical bulletin, 44(4), 550-556 (2021-04-02)
We previously reported a screening method for caloric restriction mimetics (CRM), a group of plant-derived compounds capable of inducing good health and longevity. In the present study, we explored the possibility of using this method to screen CRM drugs for
Tiziana Notarangelo et al.
Cancer cell international, 17, 86-86 (2017-10-17)
BRAF inhibitors are effective anticancer agents in BRAF-mutated melanomas. By contrast, evidences about sensitivity of thyroid carcinomas to BRAF inhibition are conflicting and it has been proposed that BRAF V600E thyroid carcinoma cells are less sensitive to BRAF inhibitors due
Girolamo Spagnoletti et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 40(4), 1010428318770957-1010428318770957 (2018-04-18)
Preoperative chemoradiation is currently the standard of care in locally advanced rectal carcinoma, even though a subset of rectal tumors does not achieve major clinically meaningful responses upon neoadjuvant chemoradiation. At present, no molecular biomarkers are available to predict response
Louis M Luttrell et al.
Science signaling, 11(549) (2018-09-27)
G protein-coupled receptors (GPCRs) use diverse mechanisms to regulate the mitogen-activated protein kinases ERK1/2. β-Arrestins (βArr1/2) are ubiquitous inhibitors of G protein signaling, promoting GPCR desensitization and internalization and serving as scaffolds for ERK1/2 activation. Studies using CRISPR/Cas9 to delete
Jackson Sapuleni et al.
Reproductive biology and endocrinology : RB&E, 20(1), 104-104 (2022-07-16)
Human granulosa-lutein cells (hGLCs) amply express sirtuin-1 (SIRT1), a NAD + -dependent deacetylase that is associated with various cellular functions. SIRT1 was shown to elevate cAMP on its own and additively with human chorionic gonadotropin (hCG), it is therefore interesting to examine
Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.
Lépjen kapcsolatba a szaktanácsadással